The Id-protein family in developmental and cancer-associated pathways

C Roschger, C Cabrele - Cell Communication and Signaling, 2017 - Springer
Inhibitors of DNA binding and cell differentiation (Id) proteins are members of the large
family of the helix-loop-helix (HLH) transcription factors, but they lack any DNA-binding motif …

The role of the ubiquitin proteasome system in glioma: analysis emphasizing the main molecular players and therapeutic strategies identified in glioblastoma …

S Maksoud - Molecular neurobiology, 2021 - Springer
Gliomas constitute the most frequent tumors of the brain. High-grade gliomas are
characterized by a poor prognosis caused by a set of attributes making treatment difficult …

The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models

N Martínez-Vélez, M Garcia-Moure, M Marigil… - Nature …, 2019 - nature.com
Pediatric high-grade glioma (pHGG) and diffuse intrinsic pontine gliomas (DIPGs) are
aggressive pediatric brain tumors in desperate need of a curative treatment. Oncolytic …

USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis

A Ma, M Tang, L Zhang, B Wang, Z Yang, Y Liu, G Xu… - Oncogene, 2019 - nature.com
Metastatic progression is the main cause of mortality in breast cancer, necessitating the
determination of the molecular events driving this process for the development of new …

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

M Andrea, T Weinschenk, V Goldfinger… - US Patent …, 2019 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the immuno …

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

M Andrea, T Weinschenk, V Goldfinger… - US Patent …, 2019 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the immuno …

ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation

R Azzarelli, A McNally, C Dell'Amico, M Onorati… - Scientific Reports, 2022 - nature.com
The growth of glioblastoma (GBM), one of the deadliest adult cancers, is fuelled by a
subpopulation of stem/progenitor cells, which are thought to be the source of resistance and …

Inhibition of ubiquitin specific protease 1 sensitizes colorectal cancer cells to DNA-damaging chemotherapeutics

X Xu, S Li, X Cui, K Han, J Wang, X Hou, L Cui… - Frontiers in …, 2019 - frontiersin.org
Mutations and altered expression of deubiquitinating enzymes (DUBs) have been found
associated with many human diseases including cancers. In this study, Ubiquitin specific …

Aberrant activation of β-catenin signaling drives glioma tumorigenesis via USP1-mediated stabilization of EZH2

L Ma, K Lin, G Chang, Y Chen, C Yue, Q Guo, S Zhang… - Cancer research, 2019 - AACR
Aberrant activation of β-catenin signaling is a critical driver for tumorigenesis, but the
mechanism underlying this activation is not completely understood. In this study, we …

Targeting the ubiquitin system in glioblastoma

N Scholz, KM Kurian, FA Siebzehnrubl… - Frontiers in …, 2020 - frontiersin.org
Glioblastoma is the most common primary brain tumor in adults with poor overall outcome
and 5-year survival of less than 5%. Treatment has not changed much in the last decade or …